Buscar
Mostrando ítems 11-20 de 643
Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
(Bentham Science Publ Ltd, 2014-01-01)
The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery ...
Vasculitis primaria del sistema nervioso central, diagnóstico diferencial de demencia subaguda: Caso clínico
(Sociedad Médica de Santiago, 2009)
Multiple Uses Of Fibrin Sealant For Nervous System Treatment Following Injury And Disease
(Biomed Central LtdLondon, 2017)
Whipple's disease with neurological manifestations - Case report
(Assoc Arquivos De Neuro- PsiquiatriaSao Paulo SpBrasil, 2004)
The influence of size and chemical composition of silver and gold nanoparticles on in vivo toxicity with potential applications to central nervous system diseases
(Dovepress, 2021)
The physicochemical and optical properties of silver nanoparticles (SNPs) and gold
nanoparticles (GNPs) have allowed them to be employed for various biomedical applications,
including delivery, therapy, imaging, and as ...
Vascular involvement of the central nervous system and systemic diseases: etiologies and MRI findings
(Springer HeidelbergHeidelbergAlemanha, 2008)
Participation of kallikrein-kinin system in different pathologies
(ELSEVIER SCIENCE BV, 2008)
The general description of kinins refers to these peptides as molecules involved in vascular tone regulation and inflammation. Nevertheless, in the last years a series of, evidences has shown that local hormonal systems, ...